{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:12:15Z","timestamp":1793862735455,"version":"4.6.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["12135"],"award-info":[{"award-number":["12135"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["12199"],"award-info":[{"award-number":["12199"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["12210"],"award-info":[{"award-number":["12210"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["261365"],"award-info":[{"award-number":["261365"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.jhep.2014.05.040","type":"journal-article","created":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T11:16:09Z","timestamp":1401880569000},"page":"770-776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection"],"prefix":"10.1016","volume":"61","author":[{"given":"Melissa E.","family":"Laird","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Mohsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darragh","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Mamdouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenaig","family":"LeFouler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armanda","family":"Casrouge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"El-Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Rafik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdel-Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Soulier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Pawlotsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"H\u00e9zode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa K.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Bonnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Izopet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanislas","family":"Pol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew L.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Fontanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.05.040_b0005","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"Lavanchy","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jhep.2014.05.040_b0010","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJMoa1315722","article-title":"Treatment of HCV with ABT-450\/r-ombitasvir and dasabuvir with ribavirin","volume":"370","author":"Feld","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.05.040_b0015","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1056\/NEJMoa1402355","article-title":"Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis","volume":"370","author":"Kowdley","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.05.040_b0020","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1306227","article-title":"Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1","volume":"370","author":"Kowdley","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.05.040_b0025","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa1402869","article-title":"ABT-450\/r-ombitasvir and dasabuvir with ribavirin for hepatitis c with cirrhosis","volume":"370","author":"Poordad","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.05.040_b0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1042\/BC20090125","article-title":"Role of lipid metabolism in hepatitis C virus assembly and entry","volume":"102","author":"Popescu","year":"2010","journal-title":"Biol Cell"},{"key":"10.1016\/j.jhep.2014.05.040_b0035","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1128\/JVI.76.14.6919-6928.2002","article-title":"Characterization of low- and very-low-density hepatitis C virus RNA-containing particles","volume":"76","author":"Andre","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.05.040_b0040","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1099\/vir.0.82033-0","article-title":"Preferential association of Hepatitis C virus with apolipoprotein B48-containing lipoproteins","volume":"87","author":"Diaz","year":"2006","journal-title":"J Gen Virol"},{"key":"10.1016\/j.jhep.2014.05.040_b0045","doi-asserted-by":"crossref","first-page":"9647","DOI":"10.1128\/JVI.00914-08","article-title":"Apolipoprotein c1 association with hepatitis C virus","volume":"82","author":"Meunier","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.05.040_b0050","doi-asserted-by":"crossref","first-page":"13783","DOI":"10.1128\/JVI.01091-07","article-title":"Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture","volume":"81","author":"Chang","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.05.040_b0055","doi-asserted-by":"crossref","first-page":"12680","DOI":"10.1128\/JVI.01476-09","article-title":"Apolipoprotein E but not B is required for the formation of infectious hepatitis C virus particles","volume":"83","author":"Jiang","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2014.05.040_b0060","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/hep.23278","article-title":"Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles","volume":"51","author":"Benga","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.05.040_b0065","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/hep.23796","article-title":"Associations between serum lipids and hepatitis C antiviral treatment efficacy","volume":"52","author":"Ramcharran","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.05.040_b0070","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1111\/j.1365-2893.2010.01394.x","article-title":"Serum lipids and their associations with viral levels and liver disease severity in a treatment-naive chronic hepatitis C type 1-infected cohort","volume":"18","author":"Ramcharran","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.05.040_b0075","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1053\/j.gastro.2010.10.004","article-title":"IL28B and the control of hepatitis C virus infection","volume":"139","author":"Balagopal","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.05.040_b0080","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2014.05.040_b0085","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2014.05.040_b0090","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2014.05.040_b0095","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1084\/jem.20130012","article-title":"IL28B expression depends on a novel TT\/-G polymorphism which improves HCV clearance prediction","volume":"210","author":"Bibert","year":"2013","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2014.05.040_b0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2014.05.040_b0105","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/jmv.23597","article-title":"Serum apolipoprotein B-100 concentration predicts the virological response to pegylated interferon plus ribavirin combination therapy in patients infected with chronic hepatitis C virus genotype 1b","volume":"85","author":"Yoshizawa","year":"2013","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2014.05.040_b0110","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2011.03.039","article-title":"High-dose pegylated interferon-alpha and ribavirin in nonresponder hepatitis C patients and relationship with IL-28B genotype (SYREN trial)","volume":"141","author":"Chevaliez","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.05.040_b0115","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/jmv.20392","article-title":"Surveillance of acute hepatitis C in Cairo, Egypt","volume":"76","author":"El Gaafary","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2014.05.040_b0120","doi-asserted-by":"crossref","first-page":"e4085","DOI":"10.1371\/journal.pone.0004085","article-title":"Symptomatic acute hepatitis C in Egypt: diagnosis, spontaneous viral clearance, and delayed treatment with 12weeks of pegylated interferon alfa-2a","volume":"3","author":"Sharaf Eldin","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2014.05.040_b0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0140-6736(08)61116-2","article-title":"Acute hepatitis C","volume":"372","author":"Maheshwari","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2014.05.040_b0130","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1172\/JCI40594","article-title":"Evidence for an antagonist form of the chemokine CXCL10 in patients chronically infected with HCV","volume":"121","author":"Casrouge","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.05.040_b0135","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa1013086","article-title":"Telaprevir for retreatment of HCV infection","volume":"364","author":"Zeuzem","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.05.040_b0140","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1002\/hep.22759","article-title":"Diagnosis, management, and treatment of hepatitis C: an update","volume":"49","author":"Ghany","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.05.040_b0145","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1086\/321909","article-title":"Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis","volume":"33","author":"Graham","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2014.05.040_b0150","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1086\/380130","article-title":"Incidence and predictors of severe liver fibrosis in human immunodeficiency virus-infected patients with chronic hepatitis C: a European collaborative study","volume":"38","author":"Martin-Carbonero","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jhep.2014.05.040_b0155","doi-asserted-by":"crossref","first-page":"F23","DOI":"10.1097\/QAD.0b013e3283391d6d","article-title":"Association of a single nucleotide polymorphism near the interleukin-28B gene with response to hepatitis C therapy in HIV\/hepatitis C virus-coinfected patients","volume":"24","author":"Rallon","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jhep.2014.05.040_b0160","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.05.040_b0165","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1742-5573-6-4","article-title":"Identifiability, exchangeability and confounding revisited","volume":"6","author":"Greenland","year":"2009","journal-title":"Epidemiol Perspect Innov"},{"key":"10.1016\/j.jhep.2014.05.040_b0170","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1371\/journal.pmed.0040028","article-title":"Most published research findings are false-but a little replication goes a long way","volume":"4","author":"Moonesinghe","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.jhep.2014.05.040_b0175","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nrmicro1645","article-title":"Replication of hepatitis C virus","volume":"5","author":"Moradpour","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.jhep.2014.05.040_b0180","first-page":"1138","article-title":"High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-alpha","volume":"90","author":"Matsuda","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.05.040_b0185","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.revmed.2008.05.020","article-title":"Antiphospholipid antibodies, antiphospholipid syndrome and viral infections","volume":"30","author":"Sene","year":"2009","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jhep.2014.05.040_b0190","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jim.2005.03.016","article-title":"Oxidation and biotinylation of beta 2 glycoprotein I glycan chains induce an increase in its affinity for anionic phospholipids similar to that obtained by the addition of anti-beta 2 glycoprotein I or anti-cardiolipin antibodies","volume":"300","author":"d\u2019Angeac","year":"2005","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jhep.2014.05.040_b0195","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10495-005-0817-3","article-title":"Recruitment of beta-2-glycoprotein 1 to cell surfaces in extrinsic and intrinsic apoptosis","volume":"10","author":"Balasubramanian","year":"2005","journal-title":"Apoptosis"},{"key":"10.1016\/j.jhep.2014.05.040_b0200","first-page":"63","article-title":"Highly sensitive detection of the group A rotavirus using apolipoprotein H-coated ELISA plates compared to quantitative real-time PCR","volume":"8","author":"Adlhoch","year":"2011"},{"key":"10.1016\/j.jhep.2014.05.040_b0205","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1053\/jhep.2001.20531","article-title":"Hepatitis B virus Dane particles bind to human plasma apolipoprotein H","volume":"33","author":"Stefas","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.05.040_b0210","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/0006-291X(80)91595-8","article-title":"Activation of human post heparin lipoprotein lipase by apolipoprotein H (beta 2-glycoprotein I)","volume":"95","author":"Nakaya","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2014.05.040_b0215","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1111\/j.1462-5822.2007.00972.x","article-title":"Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection","volume":"9","author":"Andreo","year":"2007","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.jhep.2014.05.040_b0220","doi-asserted-by":"crossref","first-page":"e26637","DOI":"10.1371\/journal.pone.0026637","article-title":"Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entry","volume":"6","author":"Maillard","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2014.05.040_b0225","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1182\/blood-2010-12-325951","article-title":"Beta(2)-glycoprotein I: a novel component of innate immunity","volume":"117","author":"Agar","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jhep.2014.05.040_b0230","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1006\/bbrc.1993.1357","article-title":"Characterization and acute phase modulation of canine apolipoprotein H (beta 2-glycoprotein I)","volume":"191","author":"Sellar","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jhep.2014.05.040_b0235","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jhep.2012.02.017","article-title":"Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: evidence for an association with interferon sensitivity","volume":"57","author":"Sheridan","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.05.040_b0240","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/hep.23592","article-title":"Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection","volume":"51","author":"Li","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.05.040_b0245","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.jhep.2011.03.015","article-title":"Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C","volume":"55","author":"Tillmann","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.05.040_b0250","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2893.2011.01553.x","article-title":"Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response","volume":"19","author":"Clark","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.05.040_b0255","doi-asserted-by":"crossref","first-page":"e1001144","DOI":"10.1371\/journal.pbio.1001144","article-title":"Genetic variation shapes protein networks mainly through non-transcriptional mechanisms","volume":"9","author":"Foss","year":"2011","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jhep.2014.05.040_b0260","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/ng.2007.22","article-title":"Genetic basis of proteome variation in yeast","volume":"39","author":"Foss","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jhep.2014.05.040_b0265","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1128\/MCB.19.11.7357","article-title":"A sampling of the yeast proteome","volume":"19","author":"Futcher","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2014.05.040_b0270","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1128\/MCB.19.3.1720","article-title":"Correlation between protein and mRNA abundance in yeast","volume":"19","author":"Gygi","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2014.05.040_b0275","doi-asserted-by":"crossref","first-page":"e1000072","DOI":"10.1371\/journal.pgen.1000072","article-title":"A genome-wide association study identifies protein quantitative trait loci (pQTLs)","volume":"4","author":"Melzer","year":"2008","journal-title":"PLoS Genet"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814003882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814003882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T21:53:08Z","timestamp":1780955588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814003882"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0168827814003882"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.05.040","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718437173.793496151","asserted-by":"object"}]},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein H expression is associated with IL28B genotype and viral clearance in hepatitis C virus infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.05.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}